BIAF bioAffinity Technologies, Inc. Common Stock

Sector: Healthcare
Industry: Diagnostics & Research
15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
BIAF Fundamental Data
Loading...
Similar Companies
Loading...
BIAF Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
BIAF Insider Transactions
Loading insider data…
BIAF News
Date Headline Sentiment
bioAffinity Technologies To Present New Data On Sputum-Based Tests In Development To Characterize Lung Inflammation And Detect Multiple Protein Biomarkers Of Lung Inflammation At CHEST 2026
81.93%
BIAF stock has given up its prior gain. bioAffinity Technologies shares were trading higher after the company announced that the Japan Patent Office issued a Notice of Allowance indicating its intention to grant a patent for the method of predicting the likelihood of lung cancer powered by the CyPath Lung test for early-stage lung cancer.
94.62%
bioAffinity Technologies Commences ~$4M Offering Of Common Stock At $6.122 Per Share
64.06%
bioAffinity Technologies shares are trading higher after the company announced that the Japan Patent Office issued a Notice of Allowance indicating its intention to grant a patent for the method of predicting the likelihood of lung cancer powered by the CyPath Lung test for early-stage lung cancer.
94.41%
bioAffinity Technologies Says Japan Patent Office Intends To Grant Patent For CyPath Lung Cancer Test
64.36%
bioAffinity Technologies Announces 100% Increase In Sales For Its CyPath Lung Test For Lung Cancer
95.73%
bioAffinity Technologies, AvMEDICAL Deliver First Joint Exhibition Of CyPath Lung
78.82%
bioAffinity Technologies shares are trading higher after the company announced it is presenting two posters highlighting CyPath Lung at the 2026 NAVREF Annual Conference.
93.98%
bioAffinity Technologies To Present Clinical And Veteran-Focused Data On CyPath Lung At NAVREF 2026 Annual Conference
70.76%
12 Health Care Stocks Moving In Friday's Intraday Session
96.14%